US2014329316A1PendingUtilityA1

Tissue repair with multipotent cells

51
Assignee: CELLCOTEC B VPriority: Mar 18, 2004Filed: Jul 21, 2014Published: Nov 6, 2014
Est. expiryMar 18, 2024(expired)· nominal 20-yr term from priority
A61L 27/3852C12N 2533/30C12N 2500/32A61P 43/00C12N 5/0602A61K 35/32C12N 2502/1317A61K 35/545B33Y 80/00C12N 2506/1307C12N 5/0655A61K 35/33A61K 35/34A61L 27/3886A61L 27/3817A61L 27/3834A61L 27/3895A61K 35/28
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the field of medical science, in particular to technology directed at repairing defects in living, preferably human, tissue. The present invention provides a method for inducing differentiation of multipotent cells to a desired cell type, as well as a method for repairing a tissue defect in a human or animal patient using the concept of said method for inducing differentiation of multipotent cells. The invention further relates to a kit for carrying out the method for repairing a tissue defect.

Claims

exact text as granted — not AI-modified
1 . A method for inducing differentiation of multipotent cells to a desired cell type comprising the step of exposing a population of the multipotent cells to a population of primary cells of the desired cell type. 
     
     
         2 . The method of  claim 1 , wherein the ratio of the number of cells in the population of primary cells to the number of cells in the population of multipotent cells is from 1:200 to 1:3. 
     
     
         3 . The method of  claim 1 , wherein the ratio of the number of cells in the population of primary cells to the number of cells in the population of multipotent cells is from 1:200 to 2:3. 
     
     
         4 . The method of  claim 1 , further comprising the step of applying the combined population of multipotent cells and the population of primary cells to a tissue defect in a patient. 
     
     
         5 . The method of  claim 4 , wherein the population of multipotent cells and/or the population of primary cells are isolated from a biopsy from the patient. 
     
     
         6 . The method of  claim 4 , wherein the combined populations of multipotent and primary cells are applied to the tissue defect without having been expanded in vitro. 
     
     
         7 . The method of  claim 1 , wherein the multipotent cells and the primary cells are human cells. 
     
     
         8 . The method of  claim 1 , wherein the population of multipotent cells and the population of primary cells are combined without having been expanded in vitro. 
     
     
         9 . The method of  claim 1 , further comprising the step of seeding the combined population of multipotent cells and primary cells onto a biocompatible scaffold. 
     
     
         10 . The method of  claim 9 , wherein the biocompatible scaffold comprises a material selected from the group consisting of metals and metal alloys, ceramics, (bio)glasses, natural and synthetic polymeric materials, and combinations thereof. 
     
     
         11 . The method of  claim 10 , wherein the biocompatible scaffold comprises a copolymer of a polyethylene glycol and a polybutylene terephthalate. 
     
     
         12 . The method of  claim 11 , wherein the biocompatible scaffold is partially or completely covered by a calcium phosphate coating. 
     
     
         13 . A method of preparing a composition for tissue repair, comprising
 combining a population of multipotent cells and a population of primary cells without having been expanded in vitro and   seeding the combined population of multipotent cells and primary cells onto a biocompatible scaffold.   
     
     
         14 . The method of  claim 13 , wherein the ratio of the number of cells in the population of primary cells to the number of cells in the population of multipotent cells is from 1:200 to 1:3 
     
     
         15 . The method of  claim 13 , wherein the ratio of the number of cells in the population of primary cells to the number of cells in the population of multipotent cells is from 1:200 to 2:3. 
     
     
         16 . The method of  claim 13 , wherein the biocompatible scaffold comprises a material selected from the group consisting of metals and metal alloys, ceramics, (bio)glasses, natural and synthetic polymeric materials, and combinations thereof. 
     
     
         17 . The method of  claim 13 , wherein the biocompatible scaffold comprises a copolymer of a polyethylene glycol and a polybutylene terephthalate. 
     
     
         18 . The method of  claim 13 , wherein the biocompatible scaffold is partially or completely covered by a calcium phosphate coating.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.